litlas
Log inCreate account

Stefan Knapp

Active 1983–2025

318
Papers
42,287
Citations
112
h-index
301
i10-index

Citations

Citations per year for Stefan Knapp1983: 2 citations1984: 2 citations1985: 2 citations1986: 13 citations1987: 6 citations1988: 7 citations1989: 12 citations1990: 14 citations1991: 5 citations1992: 15 citations1993: 7 citations1994: 9 citations1995: 6 citations1996: 11 citations1997: 12 citations1998: 26 citations1999: 18 citations2000: 25 citations2001: 28 citations2002: 25 citations2003: 29 citations2004: 50 citations2005: 34 citations2006: 62 citations2007: 92 citations2008: 139 citations2009: 186 citations2010: 203 citations2011: 276 citations2012: 365 citations2013: 470 citations2014: 643 citations2015: 818 citations2016: 655 citations2017: 575 citations2018: 605 citations2019: 1,703 citations2020: 1,853 citations2021: 1,893 citations2022: 1,590 citations2023: 1,246 citations2024: 1,866 citations2025: 911 citations2026: 40 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,820 citing papers, 27.4% of this breakdownChina: 2,333 citing papers, 13.3% of this breakdownUnited Kingdom: 1,531 citing papers, 8.7% of this breakdownGermany: 1,303 citing papers, 7.4% of this breakdownCanada: 579 citing papers, 3.3% of this breakdownItaly: 554 citing papers, 3.2% of this breakdownFrance: 545 citing papers, 3.1% of this breakdownIndia: 449 citing papers, 2.6% of this breakdownSwitzerland: 415 citing papers, 2.4% of this breakdownJapan: 376 citing papers, 2.1% of this breakdownAustralia: 364 citing papers, 2.1% of this breakdownSpain: 319 citing papers, 1.8% of this breakdown
0%27.4%Other 22.6%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology56.9%
  • Medicine24.2%
  • Computer Science6%
  • Chemistry4.1%
  • Immunology and Microbiology3%
  • Neuroscience1.3%
  • Other4.5%

Topics

  • Protein Degradation and Inhibitors7.8%
  • Ubiquitin and proteasome pathways4.3%
  • Computational Drug Discovery Methods3.8%
  • Histone Deacetylase Inhibitors Research2.7%
  • Multiple Myeloma Research and Treatments2.2%
  • Epigenetics and DNA Methylation1.9%
  • Other77.3%

Coauthors

All papers

Open in search
  1. Selective inhibition of BET bromodomains

    Authors: P. Filippakopoulos, Jun Qi, S. Picaud, Y. Shen, William Smith, O. Fedorov, Elizabeth M. Morse, T. Keates, Tyler Hickman, I. Felletar, Martin Philpott, Shonagh Munro, Michael R. McKeown, Yuchuan Wang, Amanda L. Christie, Nathan West, Michael J. Cameron, Brian E. Schwartz, Tom D. Heightman, Nicholas La Thangue, Christopher A. French, Olaf Wiest, Andrew L. Kung, Stefan Knapp, James E. Bradner - Nature 2010 cited by 4,337

  2. Trends in kinase drug discovery: targets, indications and inhibitor design

    Authors: Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov, Stefan Knapp, Helgi B. Schiöth - Nature Reviews Drug Discovery 2021 cited by 780

  3. Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family

    Authors: P. Filippakopoulos, S. Picaud, Maria Mangos, Tracy Keates, Jean‐Philippe Lambert, Dalia Baršytė-Lovejoy, I. Felletar, Rudolf Volkmer, Susanne Müller, Tony Pawson, Anne‐Claude Gingras, C.H. Arrowsmith, Stefan Knapp - Cell 2012 cited by 1,777

  4. Copper is required for oncogenic BRAF signalling and tumorigenesis

    Authors: Donita C. Brady, Matthew S. Crowe, Michelle L. Turski, G. Aaron Hobbs, Xiaojie Yao, A. Chaikuad, Stefan Knapp, Kunhong Xiao, Sharon L. Campbell, Dennis J. Thiele, Christopher M. Counter - Nature 2014 cited by 612

  5. Targeting bromodomains: epigenetic readers of lysine acetylation

    Authors: P. Filippakopoulos, Stefan Knapp - Nature Reviews Drug Discovery 2014 cited by 1,245

  6. Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses

    Authors: Henner F. Farin, Mohammed H. Mosa, Benardina Ndreshkjana, Britta M. Grebbin, Birgit Ritter, Constantin Menche, Kilian B. Kennel, Paul K. Ziegler, Lili Szabó, Julia Bollrath, Dietmar Rieder, Birgitta E. Michels, Alena Kress, Müge Bozlar, Tahmineh Darvishi, Sara Stier, Ivan-Maximilano Kur, Katrin Bankov, Rebecca Kesselring, Stefan Fichtner‐Feigl, Bernhard Brüne, Thorsten Oliver Goetze, Salah‐Eddin Al‐Batran, Christian Brandts, Wolf O. Bechstein, Peter J. Wild, Andreas Weigert, Susanne Müller, Stefan Knapp, Zlatko Trajanoski, Florian R. Greten - Cancer Discovery 2023 cited by 109

  7. The promise and peril of chemical probes

    Authors: C.H. Arrowsmith, James E. Audia, Christopher P. Austin, Jonathan B. Baell, Jonathan P. Bennett, Julian Blagg, C. Bountra, Paul E. Brennan, Peter J. Brown, Mark E. Bunnage, Carolyn Buser‐Doepner, Robert M Campbell, Adrian J. Carter, Philip Cohen, Robert A. Copeland, Ben Cravatt, Jayme L. Dahlin, Dashyant Dhanak, A.M. Edwards, Mathias Frederiksen, Stephen V. Frye, Nathanael S. Gray, Charles E. Grimshaw, David Hepworth, Trevor Howe, K. Huber, Jian Jin, Stefan Knapp, Joanne Kotz, Ryan G. Kruger, Derek Lowe, Mary M. Mader, Brian D. Marsden, Anke Mueller‐Fahrnow, Susanne Müller, Rónán C. O’Hagan, John P. Overington, Dafydd R. Owen, Saul H. Rosenberg, Ruth A. Ross, Bryan L. Roth, Matthieu Schapira, Stuart L. Schreiber, Brian K. Shoichet, M. Sundström, Giulio Superti-Furga, Jack Taunton, Leticia Toledo‐Sherman, Chris Walpole, Michael A. Walters, Timothy M. Willson, Paul Workman, Robert N. Young, William J. Zuercher - Nature Chemical Biology 2015 cited by 850

  8. PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase

    Authors: Bikash Adhikari, Jelena Božilović, Mathias Diebold, Jessica Denise Schwarz, Julia Hofstetter, Martin Schröder, Marek Wanior, Ashwin Narain, Markus Vogt, Nevenka Dudvarski Stanković, Apoorva Baluapuri, Lars Schönemann, Lorenz Eing, Pranjali Bhandare, Bernhard Küster, Andreas Schlösser, Stephanie Heinzlmeir, Christoph Sotriffer, Stefan Knapp, Elmar Wolf - Nature Chemical Biology 2020 cited by 173

  9. Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?

    Authors: Zheng Zhao, Hong Wu, Li Wang, Yi Liu, Stefan Knapp, Qingsong Liu, Nathanael S. Gray - ACS Chemical Biology 2014 cited by 428

  10. Accurate calculation of the absolute free energy of binding for drug molecules

    Authors: Matteo Aldeghi, Alexander Heifetz, Michael J. Bodkin, Stefan Knapp, Philip C. Biggin - Chemical Science 2015 cited by 398

  11. Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement

    Authors: James D. Vasta, Cesear Corona, Jennifer Wilkinson, Chad Zimprich, James R. Hartnett, Morgan R. Ingold, Kristopher Zimmerman, Thomas Machleidt, Thomas A. Kirkland, Kristin G. Huwiler, Rachel Friedman Ohana, Michael R. Slater, Paul Otto, Mei Cong, Carrow I. Wells, Benedict‐Tilman Berger, Thomas Hanke, Carina Glas, Ke Ding, David H. Drewry, K. Huber, Timothy M. Willson, Stefan Knapp, Susanne Müller, Poncho Meisenheimer, Frank Fan, Keith V. Wood, Matthew B. Robers - Cell chemical biology 2017 cited by 293

  12. Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction

    Authors: Colin K. Deniston, John Salogiannis, Sebastian Mathea, David Snead, Indrajit Lahiri, Mariusz Matyszewski, Oscar Donosa, Reika Watanabe, Jan Böhning, Andrew K. Shiau, Stefan Knapp, Elizabeth Villa, Samara L. Reck‐Peterson, Andrés E. Leschziner - Nature 2020 cited by 247

  13. Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization

    Authors: Martin P. Schwalm, Andreas Krämer, Anja Dölle, Janik Weckesser, Xufen Yu, Jian Jin, Krishna Saxena, Stefan Knapp - Cell chemical biology 2023 cited by 96

  14. The Cysteinome of Protein Kinases as a Target in Drug Development

    Authors: A. Chaikuad, Pierre Koch, Stefan Laufer, Stefan Knapp - Angewandte Chemie International Edition 2017 cited by 238

  15. Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases

    Authors: Peter Canning, C.D.O. Cooper, T. Krojer, James W. Murray, A.C.W. Pike, A. Chaikuad, Tracy Keates, Chancievan Thangaratnarajah, Viktorija Hojzan, Brian D. Marsden, O. Gileadi, Stefan Knapp, F. von Delft, Alex N. Bullock - Journal of Biological Chemistry 2013 cited by 294

  16. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

    Authors: Ariane Hammitzsch, C. Tallant, O. Fedorov, Alison O’Mahony, Paul E. Brennan, Duncan A. Hay, Fernando O. Martínez, Hussein Al‐Mossawi, Jelle de Wit, Matteo Vecellio, Christopher Wells, B P Wordsworth, Susanne Müller, Stefan Knapp, Paul Bowness - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 256

  17. Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

    Authors: Laetitia J. Martin, Manfred Koegl, Gerd Bader, Xiaoling Cockcroft, O. Fedorov, Dennis Fiegen, Thomas Gerstberger, Marco H. Hofmann, Anja Hohmann, Dirk Kessler, Stefan Knapp, Petr Knesl, Stefan Kornigg, Susanne Müller, Herbert Nar, Catherine Rogers, Klaus Rumpel, Otmar Schaaf, Steffen Steurer, C. Tallant, Christopher R. Vakoc, Markus Zeeb, Andreas Zoephel, Mark Pearson, Guido Boehmelt, Darryl B. McConnell - Journal of Medicinal Chemistry 2016 cited by 224

  18. Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

    Authors: Marek Wanior, Andreas Krämer, Stefan Knapp, Andreas C. Joerger - Oncogene 2021 cited by 165

  19. CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1

    Authors: Milan Hluchý, Pavla Gajdušková, Igor Ruiz de los Mozos, Michal Rájecký, Michael Kluge, Benedict‐Tilman Berger, Zuzana Slabá, David Potěšil, Elena Weiß, Jernej Ule, Zbyněk Zdráhal, Stefan Knapp, Kamil Paruch, Caroline C. Friedel, Dalibor Blažek - Nature 2022 cited by 90

  20. RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

    Authors: S. Picaud, Christopher Wells, I. Felletar, Deborah H. Brotherton, Sarah Martin, P. Savitsky, Beatriz Díez-Dacal, Martin Philpott, C. Bountra, Hannah Lingard, O. Fedorov, Susanne Müller, Paul E. Brennan, Stefan Knapp, P. Filippakopoulos - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 481

  21. The ins and outs of selective kinase inhibitor development

    Authors: Susanne Müller, A. Chaikuad, Nathanael S. Gray, Stefan Knapp - Nature Chemical Biology 2015 cited by 287

  22. Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

    Authors: Duncan A. Hay, Oleg Fedorov, Sarah Martin, Dean C. Singleton, C. Tallant, Christopher Wells, S. Picaud, Martin Philpott, Octovia Monteiro, Catherine Rogers, Stuart J. Conway, Timothy P. C. Rooney, Anthony Tumber, Clarence Yapp, P. Filippakopoulos, Mark E. Bunnage, Susanne Müller, Stefan Knapp, Christopher J. Schofield, Paul E. Brennan - Journal of the American Chemical Society 2014 cited by 285

  23. Mapping the Endothelial Cell S -Sulfhydrome Highlights the Crucial Role of Integrin Sulfhydration in Vascular Function

    Authors: Sofia‐Iris Bibli, Jiong Hu, Mario Looso, Andreas Weigert, Corina Rațiu, Janina Wittig, Maria Kyriaki Drekolia, Lukas Tombor, Voahanginirina Randriamboavonjy, Matthias S. Leisegang, Philipp Goymann, Fredy Delgado Lagos, Beate Fißlthaler, Sven Zukunft, Anastasia Kyselova, Alberto Fernando Oliveira Justo, Juliana Heidler, Diamantis I. Tsilimigras, Ralf P. Brandes, Stefanie Dimmeler, Andreas Papapetropoulos, Stefan Knapp, Stefan Offermanns, Ilka Wittig, Stephen L. Nishimura, Fragiska Sigala, Ingrid Fleming - Circulation 2020 cited by 107

  24. PROTAC degraders as chemical probes for studying target biology and target validation

    Authors: Václav Němec, Martin P. Schwalm, Susanne Müller, Stefan Knapp - Chemical Society Reviews 2022 cited by 83